ISM3412

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISM3412, covering 2025-12-11 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors [Phase 1]